Medzym Inc Information

Company's current focus is on Age-related eye disorders. We, however, intend to develop either internally or through in-licensing (1) Anti-Inflammatory/Allergy (2) Cardio-vascular, and (3) Tissue regeneration/Aging related diseases. This purpose has guided us to become an innovative force in the molecular medicines. The company's scientific and management credibility is well recognized. Team's credibility further manifests itself in a twenty-year history of being committed to life-threatening disease research. Medzym's first initiative is Cataract,-a scientifically simple yet catastrophically problematic situation at human's hand. A simple and large-scale applicable solution is need yesterday. Medzym believes it has all the positive indications for a simple solution to prevent this catastrophic problem. Value - We aspire to be fully GREEN